LSA
MIRM icon

Leonteq Securities AG’s Mirum Pharmaceuticals MIRM Stock Holding History

Leonteq Securities AG’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-5,000
Closed -$195K – 1305
2024
Q3 		$195K Hold
5,000
– – 0.01% 494
2024
Q2 		$171K Hold
5,000
– – 0.01% 516
2024
Q1 		$126K Hold
5,000
– – 0.01% 599
2023
Q4 		$148K Hold
5,000
– – 0.01% 562
2023
Q3 		$158K Hold
5,000
– – 0.01% 573
2023
Q2 		$129K Hold
5,000
– – 0.01% 622
2023
Q1 		$120K Hold
5,000
– – 0.01% 622
2022
Q4 		$97.5K Buy
+5,000
New +$98.8K ﹤0.01% 673

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Leonteq Securities AG's MIRM Position: Q4 2024 in Review

Leonteq Securities AG sold out of Mirum Pharmaceuticals (MIRM) in Q4 2024, closing a stake of 5,000 shares — an estimated $195K sold.

Leonteq Securities AG first reported a position in MIRM in Q4 2022 and held it in 8 quarters. The position peaked at $195K in Q3 2024. 205 funds tracked by Wall St. Rank hold MIRM as of Q4 2024.

  • Leonteq Securities AG reported no remaining Mirum Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Leonteq Securities AG sold 5,000 Mirum Pharmaceuticals shares in Q4 2024, an estimated $195K.
  • Leonteq Securities AG first reported a position in Mirum Pharmaceuticals in Q4 2022 and held it in 8 quarters.
  • Leonteq Securities AG's Mirum Pharmaceuticals position peaked at $195K in Q3 2024.
  • 205 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q4 2024.

Based on Leonteq Securities AG's 13F filing for Q4 2024, filed 23 Feb 2026.